Skip to main content
SBCSBC Medical Group Holdings IncoBuy Wait7.1·$4.54+1.79%
SBC · Concentration risk · 10-K extracted

SBC Medical Group Holdings Inco (SBC) concentration risks

Updated

The most significant concentration SBC Medical Group Holdings Inco discloses is franchisee medical corporations, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: SBC Medical Group Holdings Inco’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 2 disclosed concentrations

HIGH0
MEDIUM2
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

MEDIUMBuilt-in & outside partyCustomer

franchisee medical corporations

10-K Item 1A: 'We have substantial franchisee concentration.'
SEC 10-K · filed Mar 2026
MEDIUMBuilt-inGeographic

Japan

10-K Item 1A: 'a large percentage of revenues are concentrated with a limited number of franchisees that mainly operate the franchise locations in Japan'
SEC 10-K · filed Mar 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-08-30

SBC Medical Group's concentration profile is narrow but self-reinforcing. The company discloses a medium-share dependency on franchisee medical corporations, meaning its revenue runs through a limited set of franchisee operators rather than a broad, arm's-length customer base. That dependency is compounded by a medium-share geographic concentration in Japan, where the franchisee network is predominantly based. Read together, these are less two separate exposures than one: the franchisee reliance is a mixed dependency risk tied to the operating health of specific partners, while the Japan concentration is structural, reflecting where the network itself is built. Neither is quantified with a specific percentage in the filing, but the overlap matters — a disruption affecting a major franchisee or Japan-specific operating conditions would touch the same underlying exposure rather than diversifying the impact. For an investor, this reads as a single concentrated bet on the health of Japan's franchise operators rather than two independent, uncorrelated risks, even though the filing frames them as distinct disclosure items.

For the engine’s reasoning on SBC’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Consulting Services

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
BAHBooz Allen Hamilton Holding Cor1023
SBCSBC Medical Group Holdings Inco0202
HURNHuron Consulting Group Inc.0112
EFXEquifax, Inc.0011
CRAICRA International,Inc.0000
FCNFTI Consulting, Inc.0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks SBC Concentration risk